第九届基于片段的药物发现会议
- 2024年3月3日至5日
- 英国剑桥
Schrödinger 我们非常荣幸能参加将于3月3日至5日在英国剑桥欣克斯顿厅(Hinxton Hall)举行的第九届片段基药物发现会议。欢迎前来参观Schrödinger 公司一级首席科学家安东尼娅·库兹马尼奇(Antonija Kuzmanic)的壁报展示,题为“基于绝对自由能微扰 (AB-FEP+ )的大规模计算机辅助片段筛选 ”。
Title: Large-scale in silico Fragment Screening Based on Absolute Free Energy Perturbation (AB-FEP+)
Speaker: Antonija Kuzmanic, Principal Scientist I
Abstract: Fragment screening has witnessed remarkable success with 6 FDA approved drugs and many more in clinical trials. Here we present a computational innovation to dramatically expand the scope of fragment screening, from screening typical ~3k – 30k experimental fragment libraries to screening ~200 million fragments with high hit rates. This approach involves a virtual screening funnel based on Absolute Free Energy Perturbation to rigorously score diverse fragments based on their predicted binding affinities, allowing for only a small number of fragments (~25-50) to be purchased and/or synthesized for experimental testing. This approach has already been successfully applied during the hit finding stage for several active internal drug discovery projects, resulting in potent (nM – uM), ligand efficient (LE 0.38 – 0.51) starting points from which to initiate our discovery campaigns. In the TPL2 project, five fragments hits (<100 uM) were identified from fragment screening and were expanded to develop initial SAR, which led to discovery of the hit compounds.